Q2 2024 saw reduced revenue and increased losses as Circa focused on high-value applications and securing funding for the Resolute project, with environmental permitting expected in Q4. Market traction is growing through new partnerships in pharma and green solvents.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.